Otsuka ANZ-PKD

You are now logged in to the 3rd meeting of a 4 part series that aims to provide an update on the clinical management and science of polycystic kidney diseases (PKD) to enable clinicians and scientists in Australia and New Zealand to deliver best care and research to people with PKD.

This scientific meeting series will provide a practical update on personalised medicine, genetic diagnostics, druggable targets, clinical trials and endpoints in ADPKD.

The meeting will feature a ‘crash course’ in clinical management and include talks by patients with PKD.

Agenda (AEST)

0930 – 1000   –  Registration and morning tea
1000 – 1010   –  Welcome & Open Prof Andrew Mallett
1010 – 1040   –  Clinical Instruments to Assess Fluid and Dietary Salt Intake in ADPKD: Role of Gender Dr Annette Wong
1040 – 1110   –  Value of Machine Learning to Predict Outcomes in ADPKD A/Prof Gopi Rangan
1110 – 1120   –  Q&A Dr Annette Wong and A/Prof Gopi Rangan
1120 – 1140   –  Rab GTPases as potential modifiers of Ciliopathies Dominique McConnachie
1140 – 1150   –  Q&A Dominique McConnachie
1150 – 1250   –  Lunch
1250 – 1320   –  Non-Organoid model system based functional genomics in ADPKD, ARPKD, NPHP and cystic kidney diseases Prof Ian Smyth
1320 – 1350   –  Kidney Organoid based functional genomics in ADPKD, ARPKD, NPHP and cystic kidney diseases Dr Tom Forbes
1350 – 1400   –  Q&A Prof Ian Smyth and Dr Tom Forbes
1400 – 1415   –  Clinical trial progress in ADPKD Prof Carmel Hawley
1415 – 1425   –  Highlight on clinical trials in ADPKD: IMPEDE-PKD Prof Andrew Mallett
1425 – 1435   –  Q&A Prof Carmel Hawley and Prof Andrew Mallett
1435 – 1445   –  Patient priorities and perspectives in ADPKD and cystic kidney disease Dr Charmaine Green
1445 – 1505   –  Patient priorities and perspectives in ADPKD and cystic kidney disease Tess Harris (UK)
1505 – 1515   –  Q&A Dr Charmaine Green and Tess Harris (UK)
1515 – 1545   –  Pain Measurement in ADPKD Dr Ragada El-Damanawi (UK)
1545 – 1555   –  Q&A Dr Ragada El-Damanawi (UK)
1555 – 1600   –  Close Prof Andrew Mallett

This meeting is sponsored by Otsuka Australia Pharmaceutical Pty Ltd.
The content of this meeting, including the selection of speakers, is developed independently by a Steering Committee, with no input from Otsuka.

Otsuka Australia Pharmaceutical Pty Ltd, ABN 20 601 768 754.
Chatswood NSW 2067. Date of preparation May 2021. JIN-2104-17.02

otsuka mini
Live Streaming Australia